PRACTICES

PHARMA

CLINICAL TRIALS SUPPORT

INTELLECTUAL PROPERTY, DRUG, AND MEDICAL PRODUCT RIGHTS TRANSACTIONS

STATE AUTHORITY INSPECTION SUPPORT

HEALTHCARE PPP

CLINICAL TRIALS SUPPORT
INTELLECTUAL PROPERTY, DRUG, AND MEDICAL PRODUCT RIGHTS TRANSACTIONS
STATE AUTHORITY INSPECTION SUPPORT
HEALTHCARE PPP

Our team provides comprehensive legal support to pharmaceutical and medical companies, manufacturers of drugs, medical equipment and devices, beauty and healthcare products.

We provide structuring and support of transactions with drug and pharmaceutical substance rights, including intellectual property. We also understand the specific requirements of the Ministry of Health of the Russian Federation to registration procedures, a crucial aspect of such transactions.

Full legal support of an investment agreement and subsequent implementation of an investment project between RUSNANO and NEARMEDIC PHARMA (Obninsk, the Kaluga region) to establish a GMP facility producing nanotechnology based original drugs and drug products to implement advanced flu and ARVI treatment and prevention medications, with RUB 5+ billion in total project financing.
Supporting a license agreement with the Gamaleya National Center of Epidemiology and Microbiology to grant the right to produce and sell COVID-19 tests "SARS-CoV-2-RBD-ELISA-Gamaleya" to NEARMEDIC PLUS.
Supporting an agreement for exclusive European Union and MENA (Middle East and North Africa) distribution with one of the largest generics and consumer healthcare products manufacturers – STADA Arzneimittel AG, on behalf of an Italian collagen-based cosmetics product.
View more projects
Supporting a sale of the NEARMEDIC group by transferring 100% shares of NEARMEDIC INTERNATIONAL LIMITED (Cyprus) to NEW INVESTMENT HOLDING (a company within AFK-SISTEMA group) under the English law.
Supporting a transaction under a distribution agreement between a major pharmaceutical company, ABDI IBRAHIM Ilac Sanayi ve Ticaret A.S. (Turkey), and Sanofi Russia (a Russian subsidiary of an international French pharmaceutical holding) to transfer the rights to the drug Bronflex in Russia, as well as the rights to Bronflex trademarks to a major Russian pharmaceutical company.
Supporting a stock acquisition in German biotechnology company MedInnovation GmbH, which developed a technology for laboratory diagnosis of various human conditions based on a functional albumin blood test, on behalf of a major Russian pharmaceutical company.
Supporting a publishing business (pharmaceutical magazine) reorganization, structuring and supporting a transfer of intellectual rights within a group of companies to optimize operational financing.
Structuring and supporting an acquisition of rights for the Migrenol drug by a major Russian test system distributor Avivir from Four Ventures Enterprises Inc. (US).
Full legal support of merging the two clinic networks – NEARMEDIC (4 facilities) and DOCTOR RYADOM (12 facilities) to operate under a single brand "NEARMEDIC - DOCTOR RYADOM".
Supporting a license agreement with the Swiss Federal Institute of Technology Lausanne (Switzerland) for the patents to produce and commercialize the tuberculosis drug Macozenon (PBTZ) in Russia and the CIS.
Supporting a license and supply agreement for the Maxigesic painkiller with AFT Pharmaceuticals Limited (New Zealand).
Drafting a memorandum on legal restrictions and responsibilities in advertising and promotion of drugs and medical products in Russia for a major Russian pharmaceutical holding.
Supporting an agreement for the exclusive distribution of medical products (13 types of drug tests) in the EAEU with a major Dutch test system manufacturer Dutch Diagnostics B.V., on behalf of a major Russian pharmaceutical holding.
Supporting a distribution agreement between a Russian distributor and Promega Corporation (US), drug and genetic identification product manufacturer.
Reviewing the terms of a distribution agreement with Abbott Laboratories on behalf of a major Russian distributor of medical equipment and test systems.
Supporting agreements with Tula Pharmaceutical Factory for research and development and registration of the drug Inlarestin, an exclusive partnership agreement, and the transfer of rights to the product specification files (Inlartex and Snotum).
Development of anti-corruption regulations and drafting training materials for the “Anti-Corruption for Medical Representatives” training as requested by a Russian pharmaceutical company.
Advising on a distribution agreement with SHISEIDO CO., LTD, the largest Japanese manufacturer of cosmetics, perfumes, and hair care products
Successful protection of the antiviral drug Kagocel®’s business reputation in a lawsuit, resulting in sustained claims of the manufacturer, NEARMEDIC PHARMA, to AZHUR-MEDIA media founder, to discontinue distribution of untrue information in DoktorPiter and Fontanka.RU online news outlets and publish retractions.